ホーム > 杉原 英志/ Sugihara, Eiji

杉原 英志

ALUMNI 2026年10月現在、筑波大学が主たる所属機関ではありません

Sugihara, Eiji

藤田医科大学 , 医療科学部 研究推進ユニット 先進診断システム開発分野 , 准教授
Fujita Health University , Assosiate professor

関連記事はまだありません。

  1. 1. Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies. Yuki Nishida; Valeria Impedovo; Edward Ayoub; Natalia Baran (+31 著者) Michael Andreeff
      Blood (2026) Semantic Scholar
  2. 2. Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases. Seiji Yamada; Tetsuya Takimoto; Mina Ikeda; Eiji Sugihara (+11 著者) Hideyuki Saya
      Pathology international 76: e70113 (2026) Semantic Scholar
  3. 3. Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy. Kenji Zennami; Tetsuya Takimoto; Takuhisa Nukaya; Makoto Sumitomo (+3 著者) Ryoichi Shiroki
      Cancer science (2026) Semantic Scholar
  4. 4. Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series. Daijiro Kojima; Shigeo Ohba; Yuya Nishiyama; Kazuhide Adachi (+9 著者) Yuichi Hirose
      Clinical neurology and neurosurgery 265: 109371 (2026) Semantic Scholar
  5. 5. Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development. Yu Kato; Naoki Yamamoto; Yuichiro Uchida; Noriko Hiramatsu (+13 著者) Hideyuki Saya
      Cells 15: (2026) Semantic Scholar
  6. 6. Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development Yu Kato; Naoki Yamamoto; Yuichiro Uchida; Noriko Hiramatsu (+13 著者) Hideyuki Saya
      Cells (2026) Semantic Scholar
  7. 7. Intrachromosomal insertion as a diagnostic challenge: a hidden structural rearrangement causing recurrent duplication and deletion. Rie Kawamura; Yui Shichiri; Hideki Suzuki; Yuri Murase (+5 著者) Hiroki Kurahashi
      Molecular cytogenetics (2026) Semantic Scholar
  8. 8. Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas. Seiji Yamada; Tetsuya Takimoto; Yoshiteru Shimoda; Fumiharu Ohka (+5 著者) Eiji Sugihara
      Brain tumor pathology (2026) Semantic Scholar
  9. 9. Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas. Dat Quoc Tran; Mayu Takeda; Eiji Sugihara; Tetsuya Tsukamoto (+7 著者) Motoshi Suzuki
      Oncology research 34: 15 (2026) Semantic Scholar
  10. 10. Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing. Yui Shichiri; Hidehito Inagaki; Tasuku Mariya; Yuri Murase (+3 著者) Hiroki Kurahashi
      Prenatal diagnosis 46: 251 (2025) Semantic Scholar
  11. 11. Impact of TSC2 loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis. Ryoko Ichikawa; Tamotsu Sudo; Kyohei Takada; Akiko Ohwaki (+5 著者) Haruki Nishizawa
      Fujita medical journal 11: 155 (2025) Semantic Scholar
  12. 12. Phase II trial dedicated to non-selected, pretreated cutaneous angiosarcoma: Efficacy of nivolumab (AngioCheck Study). Yasuhiro Fujisawa; Kenjiro Namikawa; Shoichiro Ishitsuki; Koji Yoshino (+8 著者) Atsushi Otsuka
      European journal of cancer (Oxford, England : 1990) 224: 115537 (2025) Semantic Scholar
  13. 13. LCN2-mediated ferroptosis resistance in tissue homeostasis and early-stage tumorigenesis of the fallopian tube epithelium. Keiyo Imaeda; Tomohiro Tamura; Shimpei Nagai; Eiji Sugihara (+18 著者) Wataru Yamagami
      iScience 28: 112654 (2025) Semantic Scholar
  14. 14. Benzaldehyde suppresses epithelial-mesenchymal plasticity and overcomes treatment resistance in cancer by targeting the interaction of 14-3-3ζ with H3S28ph. Jun Saito; Nobuyuki Onishi; Juntaro Yamasaki; Naoyoshi Koike (+8 著者) Hideyuki Saya
      British journal of cancer (2025) Semantic Scholar
  15. 15. Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer. Yujin Kato; Ryo Seishima; Kaoru Hattori; Hirochika Kato (+8 著者) Yuko Kitagawa
      British journal of cancer (2025) Semantic Scholar
  16. 16. Comprehensive Search for Genes Involved in Thalidomide Teratogenicity Using Early Differentiation Models of Human Induced Pluripotent Stem Cells: Potential Applications in Reproductive and Developmental Toxicity Testing Yu Kato; Takeshi Inaba; Koudai Shinke; Noriko Hiramatsu (+10 著者) Hideyuki Saya
      Cells (2025) Semantic Scholar
  17. 17. mTOR-mediated p62/SQSTM1 stabilization confers a robust survival mechanism for ovarian cancer Tomohiro Tamura; Shimpei Nagai; Kenta Masuda; Keiyo Imaeda (+18 著者) Osamu Nagano
      Cancer Letters 616: 217565 (2025) Semantic Scholar
  18. 18. Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Yuko Chikaishi; Hiroshi Matsuoka; Eiji Sugihara; Mayu Takeda (+13 著者) Tetsuya Takimoto
      Cancer science (2025) Semantic Scholar
  19. 19. Exploring Fish Parvalbumins through Allergen Names and Gene Identities Johannes M. Dijkstra; Annette Kuehn; Eiji Sugihara; Yasuto Kondo
      Genes 15: (2024) Semantic Scholar
  20. 20. Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer. Taku Kato; Eiji Sugihara; Yuko Hata; Kyojiro Kawakami (+8 著者) Hiroyasu Ito
      The Prostate (2024) Semantic Scholar
1 2 3 … 6
  1. 1. がんゲノム医療結果報告書の読み方と患者への伝え方 : エキスパートパネルの実際 編集 関根 郁夫他
    医学と看護社 2020年5月 (ISBN: 9784909888105)

 1,059 total views